This story originally ran on Nov. 26.

The Delaware Court of Chancery last week dismissed with prejudice a lawsuit filed against Vermillion by shareholders George Bessenyei and Robert Goggin.

Through the lawsuit, Bessenyei and Goggin had sought to reverse Vermillion's decision to eliminate the board seat vacated by company CEO Gail Page.

The suit was part of a larger effort by Bessenyei and Goggin and their fellow Vermillion shareholder Gregory Novak to influence the direction of the company by winning control of seats on its board.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.